SpineGuard Expands Its Intellectual Property
10 Luglio 2020 - 8:00AM
Business Wire
- Original utilization of ultrasounds to
complement the DSG guidance technology
- X-Ray free determination of entry point and
trajectory in bone
- Grant of two new patents in Japan and
China
Regulatory News:
SpineGuard (Paris:ALSGD) (FR0011464452 – ALSGD), an
innovative company that deploys its DSG® (Dynamic Surgical
Guidance) sensing technology to secure and streamline the placement
of bone implants, announces today the grant of two new patents in
Japan and China.
The invention presented in the patents consists of implementing
ultrasound technology in an original manner in order to determine
without X-Rays and from the surface of the bone, the position of
the entry point and the optimal trajectory for a bone drilling
instrument.
Stéphane Bette, Deputy CEO and co-founder of SpineGuard,
said: “For several years SpineGuard has been inventing and
assembling complementary technical solutions for positioning
instruments and implants precisely and safely in bone, while
alleviating the systematic dangerous recourse to X-Ray imaging. The
invention that is validated here has the potential to complement
our DSG sensing technology. Indeed, it may allow the surgeon, or
the surgical robot, to find from the surface of the bone the
position of the entry point as well as the optimal trajectory. Once
the instrument has penetrated the entry point, our DSG sensor in
the bone will optimize the prevention of breaches. China and Japan
are the second and third largest markets for medical devices today,
they are therefore a significant stake in terms of intellectual
property. Our IP portfolio continues to strengthen and feeds our
discussions toward structuring strategic alliances.
About SpineGuard®
Founded in 2009 in France and the USA by Pierre Jérôme and
Stéphane Bette, SpineGuard is an innovative company deploying its
proprietary radiation-free real time sensing technology DSG®
(Dynamic Surgical Guidance) to secure and streamline the placement
of implants in the skeleton. SpineGuard designs, develops and
markets medical devices that have been used in over 75,000 surgical
procedures worldwide. Fifteen studies published in peer-reviewed
scientific journals have demonstrated the multiple benefits DSG®
offers to patients, surgeons, surgical staff and hospitals.
Building on these solid fundamentals and several strategic
partnerships, SpineGuard has expanded its technology platform in a
disruptive innovation: the « smart » pedicle screw launched late
2017 and is broadening the scope of applications in dental
implantology and surgical robotics. DSG® was co-invented by Maurice
Bourlion, Ph.D., Ciaran Bolger, M.D., Ph.D., and Alain Vanquaethem,
Biomedical Engineer.
For further information, visit www.spineguard.com
Disclaimer
The SpineGuard securities may not be offered or sold in the
United States as they have not been and will not be registered
under the Securities Act or any United States state securities
laws, and SpineGuard does not intend to make a public offer of its
securities in the United States. This is an announcement and not a
prospectus, and the information contained herein does and shall not
constitute an offer to sell or the solicitation of an offer to buy,
nor shall there be any sale of the securities referred to herein in
the United States in which such offer, solicitation or sale would
be unlawful prior to registration or exemption from
registration.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200709005644/en/
SpineGuard Pierre Jérôme CEO & Chairman Tel.: +33 1
45 18 45 19 p.jerome@spineguard.com
SpineGuard Manuel Lanfossi CFO Tél.: +33 1 45 18 45 19
m.lanfossi@spineguard.com
NewCap Investor Relations & Financial Communication
Mathilde Bohin / Pierre Laurent Tel.: +33 1 44 71 94 94
spineguard@newcap.eu
Grafico Azioni Spineguard (EU:ALSGD)
Storico
Da Mar 2024 a Apr 2024
Grafico Azioni Spineguard (EU:ALSGD)
Storico
Da Apr 2023 a Apr 2024